These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20177900)

  • 1. Management of small renal masses: a review.
    Remzi M; Javadli E; Ozsoy M
    World J Urol; 2010 Jun; 28(3):275-81. PubMed ID: 20177900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis.
    Kunkle DA; Uzzo RG
    Cancer; 2008 Nov; 113(10):2671-80. PubMed ID: 18816624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimally invasive ablative technique for the treatment of small renal masses.
    Gulur D; Crow P; Keeley FX
    Arch Ital Urol Androl; 2009 Jun; 81(2):100-6. PubMed ID: 19760865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal therapy for kidney cancer: a systematic review.
    Kutikov A; Kunkle DA; Uzzo RG
    Curr Opin Urol; 2009 Mar; 19(2):148-53. PubMed ID: 19188769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses.
    Salagierski M; Wojciechowska A; Zając K; Klatte T; Thompson RH; Cadeddu JA; Kaouk J; Autorino R; Ahrar K; Capitanio U;
    Eur Urol Oncol; 2018 Oct; 1(5):395-402. PubMed ID: 31158078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation versus cryoablation for T1b renal cell carcinoma: a multi-center study.
    Hasegawa T; Yamanaka T; Gobara H; Miyazaki M; Takaki H; Sato Y; Inaba Y; Yamakado K
    Jpn J Radiol; 2018 Sep; 36(9):551-558. PubMed ID: 29968201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologic outcomes for ablative therapy of kidney cancer.
    Park S; Cadeddu JA; Shingleton WB
    Curr Urol Rep; 2007 Jan; 8(1):31-7. PubMed ID: 17239314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Trends of Local Ablative Therapy Among Young Patients With Small Renal Masses in the United States.
    Kiechle JE; Abouassaly R; Smaldone MC; Shah ND; Dong S; Cherullo EE; Nakamoto D; Zhu H; Cooney MM; Kim SP
    Urology; 2015 Nov; 86(5):962-7. PubMed ID: 26341571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does renal mass ablation provide adequate long-term oncologic control?
    Faddegon S; Cadeddu JA
    Urol Clin North Am; 2012 May; 39(2):181-90, vi. PubMed ID: 22487761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probe ablative treatment for small renal masses: cryoablation vs. radio frequency ablation.
    Goel RK; Kaouk JH
    Curr Opin Urol; 2008 Sep; 18(5):467-73. PubMed ID: 18670269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass.
    Levinson AW; Su LM; Agarwal D; Sroka M; Jarrett TW; Kavoussi LR; Solomon SB
    J Urol; 2008 Aug; 180(2):499-504; discussion 504. PubMed ID: 18550123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryoablation of small kidney tumors.
    Zondervan PJ; Buijs M; de la Rosette JJ; van Delden O; van Lienden K; Laguna MP
    Int J Surg; 2016 Dec; 36(Pt C):533-540. PubMed ID: 27500963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ablative techniques for the management of kidney cancer.
    Hafron J; Kaouk JH
    Nat Clin Pract Urol; 2007 May; 4(5):261-9. PubMed ID: 17483811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation.
    Atwell TD; Schmit GD; Boorjian SA; Mandrekar J; Kurup AN; Weisbrod AJ; Chow GK; Leibovich BC; Callstrom MR; Patterson DE; Lohse CM; Thompson RH
    AJR Am J Roentgenol; 2013 Feb; 200(2):461-6. PubMed ID: 23345372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer.
    Heuer R; Gill IS; Guazzoni G; Kirkali Z; Marberger M; Richie JP; de la Rosette JJ
    Eur Urol; 2010 Feb; 57(2):223-32. PubMed ID: 19853989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Energy ablative therapy of renal tumours].
    Klingler HC
    Urologe A; 2007 May; 46(5):485-6, 488-90, 492-5. PubMed ID: 17453171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous and laparoscopic cryoablation of small renal masses.
    Finley DS; Beck S; Box G; Chu W; Deane L; Vajgrt DJ; McDougall EM; Clayman RV
    J Urol; 2008 Aug; 180(2):492-8; discussion 498. PubMed ID: 18550087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies.
    El Dib R; Touma NJ; Kapoor A
    BJU Int; 2012 Aug; 110(4):510-6. PubMed ID: 22304329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.